| Serial Number | 79084679 |
| Word Mark | DAWNRAYS |
| Filing Date | Tuesday, April 27, 2010 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Monday, April 27, 2020 |
| Registration Number | 4219862 |
| Registration Date | Tuesday, October 9, 2012 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 24, 2012 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | THE THIRD AND FOURTH CHINESE CHARACTERS THAT TRANSLATE TO "MANUFACTURE MEDICINE" OR "PHARMACEUTICAL COMPANY" |
| Description of Mark | The mark consists of the design of a circle with one half of the circle superimposed over a shaded rectangle, to the left of four Chinese characters over the term, "DAWNRAYS". |
| Goods and Services | Chemical preparations for pharmaceutical purposes for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Pharmaceutical preparations for injection for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Pharmaceutical preparations in tablet form for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Chemical preparations for medical purposes for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Prepared traditional Chinese medicines, namely, medicinal herb extracts and herb teas in preserved form for the treatment of respiratory system diseases, digestive system diseases, liver diseases, cardio-vascular system diseases and nervous system diseases; Medicines for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases in humans; Medicines in capsule form for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases |
| Pseudo Mark | DAWN RAYS |
| Transliteration Statement | The transliteration of the non-Latin characters in the mark is: DONG RUI ZHI YAO. |
| Translation of Words in Mark | The English translation of the foreign word(s) in the mark is: The first Chinese character means east, the second Chinese character means auspicious, luck, the third Chinese character means make, manufacture and the last Chinese character means medicine, drug, remedy; the combination of the first two Chinese characters has no meaning; they are Chinese trade name of the applicant; the combination of the last two Chinese characters mean pharmaceutical, pharmacy; "DAWNRAYS" appeared on the mark has no meaning in English; it is the English trade name of the applicant. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, May 10, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Suzhou Dawnrays Pharmaceutical Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Party Name | Suzhou Dawnrays Pharmaceutical Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Party Name | Suzhou Dawnrays Pharmaceutical Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Event Date | Event Description |
| Sunday, May 16, 2021 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Sunday, May 16, 2021 | DEATH OF INTERNATIONAL REGISTRATION |
| Friday, February 28, 2020 | TOTAL INVALIDATION PROCESSED BY THE IB |
| Friday, January 31, 2020 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Friday, January 31, 2020 | INVALIDATION PROCESSED |
| Friday, January 10, 2020 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Friday, May 10, 2019 | CANCELLED SECTION 71 |
| Tuesday, February 19, 2013 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, January 28, 2013 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, January 28, 2013 | FINAL DISPOSITION PROCESSED |
| Wednesday, January 9, 2013 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, October 9, 2012 | REGISTERED-PRINCIPAL REGISTER |
| Saturday, September 22, 2012 | NOTIFICATION PROCESSED BY IB |
| Tuesday, July 24, 2012 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 4, 2012 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, July 4, 2012 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, July 4, 2012 | NOTICE OF PUBLICATION |
| Monday, June 18, 2012 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Sunday, June 17, 2012 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, May 21, 2012 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, May 21, 2012 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, May 21, 2012 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, February 27, 2012 | NON-FINAL ACTION MAILED |
| Friday, February 24, 2012 | NON-FINAL ACTION WRITTEN |
| Saturday, February 11, 2012 | NOTIFICATION PROCESSED BY IB |
| Wednesday, February 1, 2012 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 31, 2012 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 31, 2012 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 11, 2012 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, January 11, 2012 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Tuesday, October 11, 2011 | NON-FINAL ACTION MAILED |
| Friday, October 7, 2011 | NON-FINAL ACTION WRITTEN |
| Thursday, October 6, 2011 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Monday, October 3, 2011 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Thursday, September 22, 2011 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, September 16, 2011 | ASSIGNED TO LIE |
| Thursday, September 1, 2011 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 10, 2011 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 10, 2011 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, August 10, 2011 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Tuesday, February 22, 2011 | FINAL REFUSAL MAILED |
| Monday, February 21, 2011 | FINAL REFUSAL WRITTEN |
| Monday, January 31, 2011 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, January 31, 2011 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, January 31, 2011 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, September 4, 2010 | REFUSAL PROCESSED BY IB |
| Tuesday, August 10, 2010 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, August 10, 2010 | REFUSAL PROCESSED BY MPU |
| Tuesday, August 10, 2010 | APPLICATION FILING RECEIPT MAILED |
| Monday, August 9, 2010 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Sunday, August 8, 2010 | NON-FINAL ACTION WRITTEN |
| Sunday, August 8, 2010 | ASSIGNED TO EXAMINER |
| Friday, August 6, 2010 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, August 5, 2010 | SN ASSIGNED FOR SECT 66A APPL FROM IB |